Background Factors Affecting Visual Acuity at Initial Visit in Eyes with Central Retinal Vein Occlusion: Multicenter Study in Japan.
central retinal vein occlusion
multicenter study
visual acuity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Nov 2021
29 Nov 2021
Historique:
received:
14
10
2021
revised:
13
11
2021
accepted:
23
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
To determine the baseline characteristics of patients with central retinal vein occlusion (CRVO) that were significantly associated with the best-corrected visual acuity (BCVA) at the initial examination. This was a retrospective multicenter study using the medical records registered in 17 ophthalmological institutions in Japan. Patients with untreated CRVO (≥20-years-of-age) who were initially examined between January 2013 and December 2017 were studied. The patients' baseline factors that were significantly associated with the BCVA at the initial examination were determined by univariate and multivariate linear regression analyses. Data from 517 eyes of 517 patients were analyzed. Univariate analyses showed that an older age ( The results indicate that an older age, a known strong factor, and the right eye were significantly associated with poorer BCVA at the initial visit to the hospital. These results suggest that functional and/or anatomical differences between the right and left eyes may be involved in these results.
Identifiants
pubmed: 34884321
pii: jcm10235619
doi: 10.3390/jcm10235619
pmc: PMC8658253
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ophthalmol Retina. 2021 May 12;:
pubmed: 33991710
J Hum Hypertens. 2001 Aug;15(8):519-22
pubmed: 11494088
Ophthalmology. 2014 Jul;121(7):1414-1420.e1
pubmed: 24679444
Br J Ophthalmol. 2021 Dec;105(12):1696-1704
pubmed: 33055088
Ophthalmic Epidemiol. 2021 Feb;28(1):70-76
pubmed: 32657647
Arch Ophthalmol. 2009 Sep;127(9):1101-14
pubmed: 19752419
Circ J. 2013;77(9):2226-31
pubmed: 23902998
Ophthalmol Ther. 2019 Jun;8(2):289-296
pubmed: 30969404
Ophthalmology. 2010 Feb;117(2):313-9.e1
pubmed: 20022117
Trans Am Ophthalmol Soc. 1981;79:371-422
pubmed: 7342407
J Thromb Haemost. 2010 Sep;8(9):1886-94
pubmed: 20492457
J Glob Health. 2019 Jun;9(1):010427
pubmed: 31131101
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40
pubmed: 16505064
Ophthalmology. 1996 Apr;103(4):551-60
pubmed: 8618752
Arch Ophthalmol. 1997 Apr;115(4):486-91
pubmed: 9109757
Ophthalmology. 1995 Oct;102(10):1434-44
pubmed: 9097789
Arch Ophthalmol. 1989 Jul;107(7):991-7
pubmed: 2751471
Clin Ophthalmol. 2019 Nov 07;13:2167-2179
pubmed: 31806930
Ophthalmology. 2011 Dec;118(12):2453-60
pubmed: 21764136
Ophthalmology. 2011 Jan;118(1):119-133.e1-2
pubmed: 20723991
Ophthalmology. 2011 Oct;118(10):2041-9
pubmed: 21715011
Graefes Arch Clin Exp Ophthalmol. 2021 Feb;259(2):343-350
pubmed: 32965652
Int J Environ Res Public Health. 2018 Aug 03;15(8):
pubmed: 30081485
J Hypertens. 2002 Jun;20(6):1089-95
pubmed: 12023677
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:121-6
pubmed: 22320929
Ophthalmologica. 1976;172(1):1-13
pubmed: 1250571
Retina. 2014 Sep;34(9):1728-35
pubmed: 24914476
Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):308-11
pubmed: 13679663
Graefes Arch Clin Exp Ophthalmol. 1990;228(3):201-17
pubmed: 2361592
J Thromb Haemost. 2015 Jul;13(7):1254-63
pubmed: 25894549
Ophthalmol Retina. 2021 Nov;5(11):1115-1124
pubmed: 33610836
Surv Ophthalmol. 2018 Nov - Dec;63(6):816-850
pubmed: 29705175
Sci Rep. 2020 Nov 12;10(1):19667
pubmed: 33184484